Tag: entrepreneurs
-
Health Care Accelerator Raises $7M for New Initiatives
17 April 2014. Healthbox Global Partners LLC, a Chicago-based business accelerator in the health care industry, says it raised $7 million to fund its operations in six cities in the U.S. as well as support new business models for encouraging innovation. Healthbox is a joint venture of Intermountain Healthcare, a health delivery system in Utah;…
-
Cancer Radiotherapy Company Lands $11.6M First Round Funds
4 April 2014. RefleXion Medical, a company in Burlingame, California designing a more accurate form of radiation therapy to treat solid tumors, gained $11.6 million in its first round of venture financing. The financing was lead by venture capital company Sofinnova Partners, with participation by Pfizer Venture Investments and Venrock. RefleXion Medical is developing a…
-
Texas Spin-Off Company Offers Stem Cell Therapy for Pets
1 April 2014. A new start-up enterprise founded by biomedical engineers at University of Texas in San Antonio offers individualized stem cell therapies for animals at veterinarians’ offices. Mobile Stem Care LLC is the creation of doctoral students Tony Yuan and Ramon Coronado that began in August 2013. Mobile Stem Cell offers an on-site lab for…
-
Investments Added to Breakout Labs Life Science Seed Grants
26 March 2014. NetScientific in Cambridge, U.K. is adding investment funds for qualified life science enterprises taking part in Breakout Labs to help them advance beyond the initial start-up phase. Under the deal, Breakout Labs portfolio companies fitting into NetScientific’s investment priorities will qualify for $250,000 in follow-on investment beyond Breakout Labs’ $350,000 in seed…
-
Biotech Partnership to Develop Non-Ricin Castor Plants
12 March 2014. Precision BioSciences Inc. and Novo Synthetix, biotechnology companies in Durham, North Carolina, are collaborating on a new type of castor bean, without the ricin poison that makes the beans difficult to process and market. Financial and intellectual property aspects of the deal were not disclosed. Beans from castor plants (Ricinus communis) have the potential to…
-
Start-Up Company Licenses University Stroke Drug Research
10 March 2014. Zocere Inc. in Albuquerque, New Mexico is licensing a neurological protein from University of New Mexico for development into a drug to protect ischemic stroke victims from extensive brain damage. Financial terms of the deal with the university’s technology transfer office were not disclosed. Nearly 800,000 people in the U.S. have a stroke each…
-
Smartphone Obstetrics App Gains $2M Angel, Public Funding
10 March 2014. LionsGate Technologies, a medical device developer in Vancouver, British Columbia, received $2 million in private and public financing for its smartphone app measuring blood oxygen levels in pregnant women. The funds will support clinical trials and scaling up for production of LionsGate’s Phone Oximeter, a device that checks for risks of developing high blood pressure…
-
Trial Shows Nasal Filter Helps Relieve Hay Fever Symptoms
7 March 2014. A clinical trial at Aarhus University in Denmark shows a small filter placed in the nose reduced symptoms of hay fever among allergy sufferers, compared to a placebo. The inventor of the filter, Peter Kenney, a doctoral candidate at Aarhus, and colleagues presented their findings earlier this week at a meeting of…
-
University, Spin-Off Partner on Enviro Flying Robotic Device
6 March 2014. University of Nevada in Reno and NevadaNano, a spin-off company from the university, are developing an aerial robotic device for environmental sensing and reporting over a large area. The project is funded by a $150,000 Small Business Technology Transfer grant from the U.S. Army. The project combines the university’s expertise in autonomous…
-
FDA Fast-Tracks Depression Drug from Northwestern Spin-Off
Naurex Inc., a biotechnology company in Evanston, Illinois, says the U.S. Food and Drug Administration granted fast-track status for its drug candidate code-named GLYX-13 to treat depression. GLYX-13 is Naurex’s lead product for treatment of central nervous system disorders. The company develops drugs for diseases of the central nervous system that stimulate N-Methyl-D-aspartate (NMDA) receptors,…